Suven Life Sciences
231.20
-4.00(-1.70%)
Market Cap₹5,129.10 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-1.70%
1M-20.56%
6M+106.83%
1Y+57.49%
5Y+365.19%
View Company Insightsright
Latest news about Suven Life Sciences
Suven Life Sciences Reports Wider Q1 Net Loss Despite Revenue Growth 5 days ago
Suven Life Sciences reported Q1 financial results with revenue increasing to ₹18.67 crore, up 85.59% year-over-year. However, net loss widened to ₹14.78 crore, nearly double the previous year's loss. Total expenses rose to ₹1,723.44 lakhs, while R&D expenses were ₹518.77 lakhs. The company's operational revenue nearly doubled, but other income decreased significantly.
Suven Life Sciences Initiates Phase 2B Trial for Novel Depression Treatment Jul 16, 2025
Suven Life Sciences Allocates 29.85 Lakh Convertible Warrants to Abakkus Fund Jul 03, 2025
Suven Life Sciences Secures ₹857 Crore Through Preferential Issue, Backed by Market Veterans May 13, 2025
Suven Life Sciences Issues Convertible Warrants and Reports Q4 FY24 Financial Results May 13, 2025